Cardiovascular Effects of CART Cell Therapy
NCT04026737
·
clinicaltrials.gov ↗
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Lymphoma
Cardiotoxicity
Risk Factor, Cardiovascular
Immunotherapy
Sponsor
Abramson Cancer Center at Penn Medicine